J-F Eliaou

448 total citations
9 papers, 315 citations indexed

About

J-F Eliaou is a scholar working on Pathology and Forensic Medicine, Gastroenterology and Genetics. According to data from OpenAlex, J-F Eliaou has authored 9 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pathology and Forensic Medicine, 2 papers in Gastroenterology and 1 paper in Genetics. Recurrent topics in J-F Eliaou's work include Celiac Disease Research and Management (2 papers), Adenosine and Purinergic Signaling (1 paper) and Peripheral Neuropathies and Disorders (1 paper). J-F Eliaou is often cited by papers focused on Celiac Disease Research and Management (2 papers), Adenosine and Purinergic Signaling (1 paper) and Peripheral Neuropathies and Disorders (1 paper). J-F Eliaou collaborates with scholars based in France and Mali. J-F Eliaou's co-authors include Jérémy Bastid, Nathalie Bonnefoy, Gilles Alberici, Armand Bensussan, J Sany, Michel Billiard, Bertrand Carlander, Jean‐Pierre Clot, Bernard Combe and B. Combe and has published in prestigious journals such as Oncogene, Annals of the Rheumatic Diseases and Bone Marrow Transplantation.

In The Last Decade

J-F Eliaou

9 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J-F Eliaou France 7 108 94 66 56 52 9 315
Zuzana Tobiásová United States 13 230 2.1× 12 0.1× 63 1.0× 29 0.5× 18 0.3× 16 511
Mary Hunt United States 6 52 0.5× 32 0.3× 32 0.5× 136 2.4× 6 0.1× 7 414
René Dziurla Germany 9 126 1.2× 6 0.1× 37 0.6× 65 1.2× 15 0.3× 10 391
Ram Narayan United States 11 32 0.3× 5 0.1× 42 0.6× 86 1.5× 65 1.3× 35 447
Chloé Bost France 12 67 0.6× 8 0.1× 74 1.1× 63 1.1× 20 0.4× 29 405
Sema İçöz Türkiye 12 47 0.4× 6 0.1× 24 0.4× 99 1.8× 39 0.8× 21 455
Amal Rayan Egypt 13 135 1.3× 7 0.1× 108 1.6× 8 0.1× 23 0.4× 34 413
Yi Zhong China 15 30 0.3× 9 0.1× 98 1.5× 20 0.4× 56 1.1× 39 441
Richard A. Sater United States 11 180 1.7× 3 0.0× 35 0.5× 26 0.5× 14 0.3× 13 354
Jason S. Weisstein United States 9 12 0.1× 11 0.1× 22 0.3× 105 1.9× 68 1.3× 10 424

Countries citing papers authored by J-F Eliaou

Since Specialization
Citations

This map shows the geographic impact of J-F Eliaou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J-F Eliaou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J-F Eliaou more than expected).

Fields of papers citing papers by J-F Eliaou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J-F Eliaou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J-F Eliaou. The network helps show where J-F Eliaou may publish in the future.

Co-authorship network of co-authors of J-F Eliaou

This figure shows the co-authorship network connecting the top 25 collaborators of J-F Eliaou. A scholar is included among the top collaborators of J-F Eliaou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J-F Eliaou. J-F Eliaou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bastid, Jérémy, et al.. (2012). ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene. 32(14). 1743–1751. 154 indexed citations
2.
Chanson, Jean‐Baptiste, J. de Sèze, J-F Eliaou, & Thierry Vincent. (2012). Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?. Lupus. 22(3). 229–232. 7 indexed citations
3.
Mohty, Mohamad, Nathalie Fegueux, Lu Zy, et al.. (2001). Enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy. Bone Marrow Transplantation. 28(4). 335–339. 31 indexed citations
4.
Eliaou, J-F, et al.. (2001). HLA-DRB1 genes and patients with late onset rheumatoid arthritis. Annals of the Rheumatic Diseases. 60(5). 531–533. 25 indexed citations
5.
Combe, Bernard, et al.. (1998). Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.. PubMed. 25(1). 94–8. 44 indexed citations
6.
Babron, Marie‐Claude, L. Greco, F. Clot, et al.. (1997). Systematic search of genetic risk factors in Celiac Disease. 61(4). 2 indexed citations
7.
Clerget‐Darpoux, Françoise, F. Bouguerra, R Kastally, et al.. (1994). High risk genotypes for celiac disease.. PubMed. 317(10). 931–6. 16 indexed citations
8.
Carlander, Bertrand, J-F Eliaou, & Michel Billiard. (1993). Autoimmune hypothesis in narcolepsy. Neurophysiologie Clinique. 23(1). 15–22. 35 indexed citations
9.
Eliaou, J-F, et al.. (1983). [Infectious endocarditis in the neonatal period].. PubMed. 38(8). 561–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026